Teacher Retirement System of Texas Sells 75,317 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Teacher Retirement System of Texas trimmed its stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 73.9% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 26,534 shares of the medical instruments supplier's stock after selling 75,317 shares during the quarter. Teacher Retirement System of Texas owned approximately 0.12% of LeMaitre Vascular worth $2,226,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently bought and sold shares of LMAT. Opal Wealth Advisors LLC bought a new position in shares of LeMaitre Vascular during the 1st quarter worth approximately $26,000. Smartleaf Asset Management LLC lifted its holdings in LeMaitre Vascular by 234.4% during the 4th quarter. Smartleaf Asset Management LLC now owns 418 shares of the medical instruments supplier's stock worth $39,000 after purchasing an additional 293 shares during the last quarter. CBIZ Investment Advisory Services LLC lifted its holdings in LeMaitre Vascular by 38.5% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 421 shares of the medical instruments supplier's stock worth $39,000 after purchasing an additional 117 shares during the last quarter. NBC Securities Inc. acquired a new stake in LeMaitre Vascular during the 1st quarter worth approximately $36,000. Finally, Huntington National Bank lifted its holdings in LeMaitre Vascular by 64.9% during the 4th quarter. Huntington National Bank now owns 1,156 shares of the medical instruments supplier's stock worth $107,000 after purchasing an additional 455 shares during the last quarter. 84.64% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other news, CEO George W. Lemaitre sold 76,868 shares of LeMaitre Vascular stock in a transaction on Monday, May 19th. The stock was sold at an average price of $85.79, for a total value of $6,594,505.72. Following the transaction, the chief executive officer owned 1,796,783 shares in the company, valued at approximately $154,146,013.57. This trade represents a 4.10% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Over the last ninety days, insiders sold 100,000 shares of company stock valued at $8,556,857. 9.50% of the stock is owned by insiders.

LeMaitre Vascular Stock Performance

NASDAQ:LMAT traded down $2.07 during mid-day trading on Friday, hitting $83.68. 84,551 shares of the stock were exchanged, compared to its average volume of 170,219. The stock has a market capitalization of $1.89 billion, a price-to-earnings ratio of 42.26, a price-to-earnings-growth ratio of 2.21 and a beta of 0.82. The firm's 50-day simple moving average is $82.72 and its 200 day simple moving average is $88.07. The company has a debt-to-equity ratio of 0.48, a quick ratio of 13.83 and a current ratio of 16.49. LeMaitre Vascular, Inc. has a fifty-two week low of $71.42 and a fifty-two week high of $109.58.

LeMaitre Vascular (NASDAQ:LMAT - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The medical instruments supplier reported $0.48 earnings per share for the quarter, missing the consensus estimate of $0.50 by ($0.02). The firm had revenue of $59.87 million for the quarter, compared to analyst estimates of $57.61 million. LeMaitre Vascular had a return on equity of 13.53% and a net margin of 19.96%. The business's revenue for the quarter was up 12.0% on a year-over-year basis. During the same period in the previous year, the business posted $0.44 earnings per share. As a group, equities analysts anticipate that LeMaitre Vascular, Inc. will post 1.94 EPS for the current fiscal year.

LeMaitre Vascular Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, May 29th. Shareholders of record on Thursday, May 15th were issued a $0.20 dividend. The ex-dividend date of this dividend was Thursday, May 15th. This represents a $0.80 annualized dividend and a yield of 0.96%. LeMaitre Vascular's dividend payout ratio is presently 40.40%.

LeMaitre Vascular Profile

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.